Our Experiences With Natural Natural Products As Potential Therapeutic Agents : Towards Safer & Cost Effective Therapy Dr. Mrs.Chanda Kulkarni. MBBS; MD;

Slides:



Advertisements
Similar presentations
FRISC II: Fragmin and fast Revascularization during InStability in Coronary artery disease - LONG-TERM HEPARIN - Purpose To assess efficacy of long-term.
Advertisements

Randomized controlled trials
Post Research Benefits Mandika Wijeyaratne MS, MD, FRCS Dept. of Surgery, Colombo.
Presentation of BE data in a product dossier Drs. Jan Welink Training workshop: Training of BE assessors, Kiev, October 2009.
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Rare Film Guide Slide Set. Clinical Trial Design for Pirfenidone Study Purpose of Study: To see if the use of pirfenidone decreases the loss of lung function.
Metoclopramide versus Hydromorphone for the ED Treatment of Migraine Headaches Justin Griffith, MD Mark Mycyk, MD Demetrios Kyriacou, MD, PhD ICEP Resident.
Basic Design Consideration. Previous Lecture Definition of a clinical trial The drug development process How different aspects of the effects of a drug.
A randomized controlled trial of citalopram on migraine frequency Satnam S. Nijjar, M.D. Department of Neurology, Johns Hopkins School of Medicine.
St John’s wort for major depression (Review) Linde, Berner & Kriston (2008/9)
Clinical trial The Way We Make Progress Against Disease Prof. Ashry Gad Mohamed Prof. of Epidemiology College of Medicine & KKUH.
1 Points to Consider of Protocol on Multinational Trial Masaaki Kuwahara, Ph.D. Takeda Chemical Industries, Ltd. The 4th Kitasato-Harvard symposium,
Clinical Trials Scientific Aspects AND Legal & Procedural Aspects M K Unnikrishnan [Aug 2006]
Effectiveness Evaluation for Therapeutic Drugs for Non-Food Animals
Badrul A. Chowdhury, MD, PhD
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Howard Fillit, MD Executive Director Improving Animal Trials for Alzheimer’s Disease: Recommendations for Best Practices.
Stages of drug development
© CAMS Trial 2001 CAMS Study A Multicentre Randomised Controlled Trial of Cannabinoids in Multiple Sclerosis Principle Investigators Dr John Zajicek Dr.
Yesterday, today, and tomorrow
Reading Scientific Papers Shimae Soheilipour
Pulmonary and Allergy Drugs Advisory Committee January 17, 2002 Pulmonary and Allergy Drugs Advisory Committee Meeting Gaithersburg, Maryland January 17,
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
CLAIMS STRUCTURE FOR SLE Jeffrey Siegel, M.D. Arthritis Advisory Committee September 29, 2003.
#1 STATISTICS 542 Intro to Clinical Trials Quality of Life Assessment.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
1 SNDA Gemzar plus Carboplatin Treatment of Late Relapsing Ovarian Cancer.
 A test of a new intervention or treatment on people.
Raymond F. Anton, MD for The COMBINE Study Research Group
How to Participate in Research Eric Kleerup, M.D. & Donald Tashkin, M.D. David Geffen School of Medicine at UCLA Los Angeles, California.
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
1 Study Design Issues and Considerations in HUS Trials Yan Wang, Ph.D. Statistical Reviewer Division of Biometrics IV OB/OTS/CDER/FDA April 12, 2007.
DOSE-AHF Diuretic Optimization Strategies Evaluation in Acute Heart Failure Duke Heart Failure Research Pager:
1 EFFICACY OF SHORT COURSE AMOXICILLIN FOR NON-SEVERE PNEUMONIA IN CHILDREN (Hazir T*, Latif E*, Qazi S** AND MASCOT Study Group) *Children’s Hospital,
“Journey of a Drug” From Test Tube TO Prescribing Physician.
CLINICAL TRIALS – PHASE IV. PHASE IV  Phase IV are post marketing studies and provide basis for continued marketing. They may also provide information.
Clinical Trials - PHASE II. Introduction  Important part of drug discovery process  Why important??  Therapeutic exploratory trial  First time in.
CDER / FDA1 Clinical Study Options for locally acting nasal suspension products Robert J. Meyer, MD Director, Div. Of Pulmonary and Allergy Drug Products.
ASCEND-HF Acute Study of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure Duke Heart Failure Research Pager:
Joint Non-Prescription Drugs and Pediatric Advisory Committee Meeting October 18-19, 2007 Considerations for Extrapolation of Efficacy from Adults to Children.
From: PLOS Neglected Tropical DiseaseJanuary 2014 Presented by Pavitra Charoensrisakkul and Peeraya Permkarnjaroen 3 rd year medical cadet Phramongkutklao.
Is a Clinical Trial Right for Me?
Trials Adrian Boyle.
Patient Focused Drug Development An FDA Perspective
Eucrisa™ - Crisaborole
Volume 357, Issue 9273, Pages (June 2001)
Kavita, Dinesh Kumar Sharma, Renu Vij, Jatinder Singh
Clinical Research Contribution towards improving Clinical Care
Mustafa Serinken MD, Cenker Eken MD, Kamil Tunay MD, Yalcin
Case Studies in Big Data and Analysis
Quality of Life Assessment
Pharmacological and Behavioral
Prof. Dr. Basavaraj K. Nanjwade
Pharmaceutical Care Plan
Design of Clinical Trials
A Randomised Cross Over Comparison of Trehalose/Hyaluronate Eye Drops and Standard Treatment: Patient Satisfaction in the Treatment of Dry Eye Syndrome.
Bozeman Health Clinical Research
Nat. Rev. Nephrol. doi: /nrneph
This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.
Is a Clinical Trial Right for Me?
Muro Pharmaceutical, Inc. An ASTA Medica company March 20, 2001
انواع مطالعات توصيفي تحليلي مشاهده اي مداخله اي گزارش مورد گزارش موارد
Issues in Hypothesis Testing in the Context of Extrapolation
Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to- Severe Osteoarthritis Pain  Jacques R. Caldwell, MD, Ronald J. Rapoport,
Tim Auton, Astellas September 2014
Best Practices in the Clinical Management of Motor Symptoms Associated With Huntington Disease.
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Jonathan Davis, MD Chief of Newborn Medicine
Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray  Eli O. Meltzer,
Difference between the groups
Presentation transcript:

Our Experiences With Natural Natural Products As Potential Therapeutic Agents : Towards Safer & Cost Effective Therapy Dr. Mrs.Chanda Kulkarni. MBBS; MD; Ph.D; FSASMS Prof. & Head, Pharmacology St. John’s Medical College INDIA HE SHALL LIVE BECAUSE OF ME

Problem Statement : Natural Products [NPs] NPs : Are used in routine daily life as dietary components & as medications. NPs : As therapeutic agents is not explored scientifically. NPs : Are proposed to be cost effective & have low toxicity profile. NPs : May form an attractive treatment option in chronic illnesses.

Objectives : Clinical Trials In Patient Population – To Evaluate : Efficacy & Safety of polyherbal preparations. To Evaluate : Anti-dandruff & Anti- allergic Rhinitis activity.

Methods - Interventions : IERB Approval Enroll Patients Diagnosis & Clinical Examination Investigations Selection – inclusion / exclusion Informed Consent

Design : Anti-Dandruff - Open Label, Prospective, Multicentric study. Anti-Allergic - Randomised, Double Blind, Placebo Controlled study.

Setting & Patients : Methods ANTI – DANDRUFF : Poly-Herbal Hair Oil Total Pts. N = males14 females 4 dropouts

Patient Selection : Methods  INCLUSION : Moderate-Severe Normal-physical /clinical  EXCLUSION : Pts. with scanty hair Pts. with endocrine imbalance  TREATMENT : 10 ml.twice/day x 2 wks 3 visits with follow up  PARAMETERS : Severity of itching Degree of scalp scaling Clinical & Patient Assessment VAS Overall / Global Improvement

18 Statistics & Results Pre & post treatment scores for Itching & White Scales compared using Paired ‘t’ test No.of Pts. Improve. 8/21 > 75% 10/21 50% – 75% 3/21 < 50% P < 0.001

Allergic Rhinitis : Methods No.of Pts. N=48 Test, N=24 Placebo, N=24 12 M + 12 F 14 M + 10 F C, N =20 D, N=4 C, N=20 D, N=4 PAR, N=15 SAR, N=5 PAR, N=13 SAR, N=7 Inclusion & Exclusion Criteria PatientSelection

Outcome Measures : Methods Before & After Treatment 1.Clinical & Patient Assessment Nasal & non-nasal symptoms – 4 occasions a] Arbitrary scale – Objectively b] VAS – Subjectively 0 to 100 mm. 2.Assessment of Quality of Life Seven disease related domains – sleep, non- hay fever,practical problems, nasal & eye symptoms, emotional function, overall rating.

Statistical Methods : 1.Comparison of nasal / non-nasal symptoms by students ‘t’ test. 2.Use of r escue medications in test Vs placebo group - Chi squared test. Results : 1. Overall improvement – 10/20 = < 75% 2. Clinical improvement – 14/20

The POLYHERBAL Anti-Dandruff & Anti- Allergic Rhinitis formulations proved effective & Safe  Type of Formulation  Multiple ingredients  Method of use  Duration of treatment Conclusions : Drawbacks :

Morphin e Atropine Digoxin Theophylline Isolation of active molecules Elucidation of structure Biological activity Lead Compounds

Issues for Concern :  Natural Variations  Manufacturing Variations  Analytical methods  Standardization

Acknowledgements : Himalaya Drug Company Pvt. Ltd. Natural Remedies Pvt. Ltd. Dr. Vaijayanthi Dr. Subhashchandra Shetty Dr. Pratibha Nadig Dr. V. S. Saxena, Dr. Bagchi